We are the top enrolling site in the US for a study of a novel HIV treatment that has been granted Fast Track Designation by the FDA.

Experience in recruiting special populations and accelerating start-up and enrollment: Recently a sponsor approached us to assist them in recruiting enough hypogonadal volunteers for a time-critical bioequivalence study. We successfully pre-screened 113 volunteers in a period of 7 days; we identified 72 hypogonadal men that met the inclusion criteria for the study. The study required 44 subjects to be available for randomization (40 subjects to receive study drug plus 4 alternates). The sponsor had very strict timelines for recruitment; we went from contract execution to completing dose administration for 40 subjects in a matter of just 31 days!! 40 subjects received study drug during 4 separate treatment periods; 38 subjects completed 100% of the study visits. Floridian Clinical Research completed the study on time, on budget, and with a 95% completion / patient retention rate.